Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Apyx Medical Q4 2024 GAAP EPS $(0.12) Beats $(0.15) Estimate, Sales $14.22M Beat $13.39M Estimate

Author: Benzinga Newsdesk | March 13, 2025 07:02am
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 57.14 percent increase over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $14.22 million which beat the analyst consensus estimate of $13.39 million by 6.21 percent. This is a 3.01 percent decrease over sales of $14.66 million the same period last year.

Posted In: APYX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist